MarketScreener Editorial Features Celyad Oncology SA
Equities
CYAD
BE0974260896
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1710 EUR | -3.39% |
|
-2.29% | +0.59% |
| 25-09-30 | Celyad Oncology to Sell Belgian Research Facility for EUR3 Million | MT |
| 25-09-29 | Celyad Oncology announces research facility divestiture | RE |
MarketScreener Editorial Features
Search
 | Global markets live: Boohoo, KBC, Vodafone, Home Depot, Ford... | May 16, 2023 at 12:01 pm EDT |
 | Global markets live: Bayer, HP, Shell, Toshiba, Citigroup... | March 01, 2022 at 11:40 am EST |
 | Global markets live: Apple, Volkswagen, Uber, Rolls-Royce, Gamestop... | December 09, 2021 at 11:56 am EST |
 | Global markets live: Daimler, Delivery Hero, Foxconn, China Evergrande, Kraft Heinz... | November 11, 2021 at 11:45 am EST |
 | Global markets live: Square, Adidas, Peloton Interactive... | May 07, 2021 at 09:55 am EDT |
 | GLOBAL MARKETS LIVE: Deliveroo, Zurich Insurance, Bayer… | January 18, 2021 at 09:12 am EST |
 | GLOBAL MARKETS LIVE: Alibaba, Tesla, Delivery Hero… | January 07, 2021 at 10:36 am EST |
 | Nissan wants to divorce Renault, weak sales for Ford in China, Boeing’s crisis spreads… | January 13, 2020 at 10:05 am EST |
No results for this search
- Stock Market
- Equities
- CYAD Stock
- News Celyad Oncology SA
- MarketScreener Editorial Features
Select your edition
All financial news and data tailored to specific country editions
